Generation Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.

About GBIO

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. 

CEO
Cameron Geoffrey McDonough
CEOCameron Geoffrey McDonough
Employees
115
Employees115
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2016
Founded2016
Employees
115
Employees115

GBIO Key Statistics

Market cap
38.93M
Market cap38.93M
Price-Earnings ratio
-0.55
Price-Earnings ratio-0.55
Dividend yield
Dividend yield
Average volume
54.47K
Average volume54.47K
High today
$6.00
High today$6.00
Low today
$5.77
Low today$5.77
Open price
$5.99
Open price$5.99
Volume
63.58K
Volume63.58K
52 Week high
$25.70
52 Week high$25.70
52 Week low
$3.00
52 Week low$3.00

GBIO News

TipRanks 6d
Generation Bio CEO McDonough to step down, Howze named interim CEO

Generation Bio (GBIO) announced that Geoff McDonough will step down as CEO and president and will become chair of the company’s board of directors. The board ha...

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own GBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.